Infectious Disease

Pandemic Public Health Approaches, C. difficile Guide

ADD SUBJECT TO EMAIL ALERTS

Receive an email when new articles are published on

Please enter your email address to receive an email when new articles are published on . “data-action =” subscribe “> subscribe

We could not process your request. Please try again later. If this problem persists, please contact customerservice@slackinc.com.

Back to Healio

The research presented at the World Microbe Forum virtual meeting analyzed the number of cases and deaths in the US during the first three months of the pandemic and identified public health approaches that reduced deaths related to COVID-19.

A report on the data was the top infectious disease story last week.

Another top story related to new guidelines for the management of Clostridioides difficile. Recommendations include the use of fidaxomicin for initial C. difficile episodes and bezlotoxumab plus standard antibiotics for recurrent episodes within the last 6 months.

Read these and other top infectious disease stories below:

Researchers identify variables related to COVID-19 deaths during the first wave

Long-term infrastructure and short-term interventions had the biggest impact on reducing COVID-19 deaths in the United States during the first wave, according to new research. Continue reading.

IDSA, SHEA Update Guide for Treating Patients With It is difficult

The Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America (SHEA) have published new guidelines for the treatment of Clostridioides difficile. Continue reading.

Researchers identify gut bacteria that inhibit SARS-CoV-2

Researchers from South Korea examined common gut bacteria for activity against SARS-CoV-2 and found a bacterium that makes compounds that inhibit the coronavirus, according to new results presented on the virtual World Microbe Forum. Continue reading.

U.S.. sees “shameful” increase in congenital syphilis cases

For 6 years in a row, the CDC’s annual sexually transmitted disease surveillance report has contained a dire warning: After years of decline, cases of chlamydia, gonorrhea and syphilis have steadily increased. Continue reading.

Bezlotoxumab reduces the chance of a relapse It is difficult Infection in transplant recipients

Bezlotoxumab significantly reduced the incidence of recurrent Clostridioides difficile infections in solid organ and haematopoietic cell transplant recipients, according to a study published in the Open Forum Infectious Diseases. Continue reading.

ADD SUBJECT TO EMAIL ALERTS

Receive an email when new articles are published on

Please enter your email address to receive an email when new articles are published on . “data-action =” subscribe “> subscribe

We could not process your request. Please try again later. If this problem persists, please contact customerservice@slackinc.com.

Back to Healio

Related Articles